Search Results - "Lathi, Ellen"

Leptomeningeal Enhancement on 3D‐FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice by Titelbaum, David S., Engisch, Renate, Schwartz, Eric D., Napoli, Salvatore Q., Sloane, Jacob A., Samaan, Soleil, Katz, Joshua D., Lathi, Ellen S.

“…ABSTRACT BACKGROUND AND PURPOSE Meningeal inflammation is implicated in cortical demyelination and disability progression in multiple sclerosis (MS)…”
Get full text

Low Body Weight as a Potential Surrogate Risk Factor for Progressive Multifocal Leukoencephalopathy (P2.244) by Foley, John, Gudesblatt, Mark, Zarif, Myassar, Lathi, Ellen

“…Abstract only…”
Get full text

Recommendations for cognitive screening and management in multiple sclerosis care by Kalb, Rosalind, Beier, Meghan, Benedict, Ralph HB, Charvet, Leigh, Costello, Kathleen, Feinstein, Anthony, Gingold, Jeffrey, Goverover, Yael, Halper, June, Harris, Colleen, Kostich, Lori, Krupp, Lauren, Lathi, Ellen, LaRocca, Nicholas, Thrower, Ben, DeLuca, John

“…Purpose: To promote understanding of cognitive impairment in multiple sclerosis (MS), recommend optimal screening, monitoring, and treatment strategies, and…”
Get full text

Symptom stability throughout Ocrelizumab infusion cycle in patients with Multiple Sclerosis: final results of SYMptom Burden on Ocrelizumab, a Longitudinal Study (SYMBOLS) (P7-3.017) by Kister, Ilya, Oh, Cheongeun, Douglas, Elizabeth, O’Shea, Isabella, Bacon, Tamar, Bouley, Andrew, Lathi, Ellen, Katz, Joshua

“…Abstract only…”
Get full text

Neurofilament Serum Levels Do Not Correlate with Symptom Burden in Stable, Ocrelizumab-Treated MS Patients Enrolled into SYMptom Burden on Ocrelizumab, a Longitudinal Study (SYMBOLS) (P1-1.Virtual) by McCluskey, Madaline, Oh, Cheongeun, Jungquist, Rose-Marie, Rimler, Zoe, Douglas, Elizabeth, Bouley, Andrew, Lathi, Ellen, Katz, Joshua, Kister, Ilya

“…Abstract only…”
Get full text

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial by Foley, John F, Defer, Gilles, Ryerson, Lana Zhovtis, Cohen, Jeffrey A, Arnold, Douglas L, Butzkueven, Helmut, Cutter, Gary, Giovannoni, Gavin, Killestein, Joep, Wiendl, Heinz, Smirnakis, Karen, Xiao, Shan, Kong, George, Kuhelj, Robert, Campbell, Nolan, van der Walt, Anneke, Dwyer, Christopher, Buzzard, Katherine, Spies, Judith, Parratt, John, van Pesch, Vincent, Willekens, Barbara, Perrotta, Gaetano, Bartholomé, Emmanuel, Grand'Maison, Francois, Jacques, Francois, Giacomini, Paul, Vosoughi, Reza, Girard, Jean-Marc, de Seze, Jerome, Lebrun Frenay, Christine, Ruet, Aurelie, Laplaud, David-Axel, Reifschneider, Gerd, Wagner, Bert, Rauer, Sebastian, Pul, Refik, Seipelt, Maria, Berthele, Achim, Klotz, Luisa, Kallmann, Boris-Alexander, Paul, Friedemann, Achiron, Anat, Lus, Giacomo, Centonze, Diego, Patti, Francesco, Grimaldi, Luigi, Hupperts, Raymond, Frequin, Stephan, Fermont, Jiske, Madueno, Sara Eichau, Alonso Torres, Ana Maria, Costa-Frossard França, Lucienne, Meca-Lallana, Jose Eustasio, Ruiz, Luis Brieva, Pearson, Owen, Rog, David, Evangelou, Nikolaos, Ismail, Azza, Lathi, Ellen, Fox, Edward, Leist, Thomas, Sloane, Jacob, Wu, Gregory, Khatri, Bhupendra, Steingo, Brian, Thrower, Ben, Gudesblatt, Mark, Calkwood, Jonathan, Bandari, Daniel, Scagnelli, John, Laganke, Christopher, Robertson, Derrick, Kipp, Lucas, Belkin, Martin, Cohan, Stanley, Goldstick, Lawrence, Courtney, Ardith, Vargas, Wendy, Sylvester, Andrew, Srinivasan, Jayshri, Kannan, Meena, Picone, Maryann, English, Jeffrey, Napoli, Salvatore, Balabanov, Roumen, Zaydan, Islam, Nicholas, Jacqueline, Kaplan, Jeffrey, Lublin, Fred, Riser, Emily, Miller, Tamara, Alvarez, Enrique, Wray, Sibyl, Gross, Jeffrey, Pawate, Siddharama, Hersh, Carrie, McCarthy, Lucas, Crayton, Heidi, Graves, Jennifer

“…Treatment with natalizumab once every 4 weeks is approved for patients with relapsing-remitting multiple sclerosis, but is associated with a risk of…”
Get full text

Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk by Patsopoulos, Nikolaos A., Beecham, Ashley H., Goris, An, Dubois, Bénédicte, D’hooghe, Marie B., Van Damme, Philip, Søndergaard, Helle Bach, Sellebjerg, Finn, Ullum, Henrik, Thørner, Lise W., Werge, Thomas, Damotte, Vincent, Fontaine, Bertrand, Lathrop, Mark, Gourraud, Pierre-Antoine, Pongratz, Viola, Gasperi, Christiane, Bayas, Antonios, Heesen, Christoph, Linker, Ralf, Paul, Friedemann, Stangel, Martin, Tackenberg, Björn, Bergh, Florian Then, Wildemann, Brigitte, Tumani, Hayrettin, Gold, Ralf, Grummel, Verena, Knier, Benjamin, Lill, Christina M., Dardiotis, Efthimios, Agliardi, Cristina, Barizzone, Nadia, Mascia, Elisabetta, Bernardinelli, Luisa, Cusi, Daniele, Ferrè, Laura, Comi, Cristoforo, Galimberti, Daniela, Leone, Maurizio A., Mescheriakova, Julia, Hintzen, Rogier, van Duijn, Cornelia, Teunissen, Charlotte E., Bos, Steffan D., Myhr, Kjell-Morten, Celius, Elisabeth G., Lie, Benedicte A., Comabella, Manuel, Montalban, Xavier, Alfredsson, Lars, Stridh, Pernilla, Hillert, Jan, Piehl, Fredrik, Jelčić, Ilijas, Martin, Roland, Sospedra, Mireia, Hawkins, Clive, Hysi, Pirro, Karpe, Fredrik, Khadake, Jyoti, Lachance, Genevieve, Neville, Matthew, Santaniello, Adam, Caillier, Stacy J., Calabresi, Peter A., Cross, Anne, Davis, Mary F., de Bakker, Paul I.W., Delgado, Silvia, Dembele, Marieme, Edwards, Keith, Fitzgerald, Kathryn C., Hakonarson, Hakon, Konidari, Ioanna, Lathi, Ellen, Manrique, Clara P., Pericak-Vance, Margaret A., Piccio, Laura, Schaefer, Cathy, McCabe, Cristin, Hadjigeorgiou, Georgios, Taylor, Bruce, Tajouri, Lotti, Charlesworth, Jac, Booth, David R., Harbo, Hanne F., Ivinson, Adrian J., Hauser, Stephen L., Compston, Alastair, Stewart, Graeme, Zipp, Frauke, Barcellos, Lisa F., Baranzini, Sergio E., Martinelli-Boneschi, Filippo, Ziegler, Andreas, McCauley, Jacob L., Sawcer, Stephen J., De Jager, Philip L., Kockum, Ingrid

“…Multiple sclerosis is a complex neurological disease, with ∼20% of risk heritability attributable to common genetic variants, including >230 identified by…”
Get full text

Assessing ‘No Evidence of Disease Activity’ Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study by Weinstock-Guttman, Bianca, Medin, Jennie, Khan, Nasreen, Korn, Jonathan R., Lathi, Ellen, Silversteen, Jason, Calkwood, Jonathan, Silva, Diego, Zivadinov, Robert

“…Background ‘No evidence of disease activity’ (NEDA), a composite measure of clinical and magnetic resonance imaging outcomes, provides a comprehensive…”
Get full text

Real-world Effectiveness of Delayed-release Dimethyl Fumarate in Relapsing-remitting Multiple Sclerosis Patients Who Are Treatment-naïve or Treated With Only One Prior Therapy: Final Results from the EFFECT Study (P6.373) by Calkwood, Jonathan, Cohan, Stanley, Chan, Andrew, Lathi, Ellen, Van Der Walt, Anneke, Wu, Fan, Min, Jinny, Taylor, Catherine

“…Abstract only…”
Get full text

No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study by Zivadinov, Robert, Khan, Nasreen, Korn, Jonathan R., Lathi, Ellen, Silversteen, Jason, Calkwood, Jonathan, Kolodny, Scott, Silva, Diego, Medin, Jennie, Weinstock-Guttman, Bianca

“…Objective: The impact of multiple sclerosis (MS) center type on outcomes has not been investigated. This study aimed to evaluate baseline characteristics and…”
Get full text

Prospective growth and developmental outcomes in infants born to mothers with multiple sclerosis by Mahlanza, Tatenda Dawn, Manieri, Maria Claudia, Klawiter, Eric C, Solomon, Andrew J, Lathi, Ellen, Ionete, Carolina, Berriosmorales, Idanis, Severson, Christopher, Stankiewicz, James, Cabot, Ann, Elkort, Michael, Chitnis, Tanuja, Bove, Riley, Katz, Joshua, Houtchens, Maria

“…Background: The importance of supporting pregnancy-related decisions in multiple sclerosis (MS) patients has increasingly been recognized and hence the need…”
Get full text

No Increase in Symptoms Toward the End of the Ocrelizumab Infusion Cycle in Patients With Multiple Sclerosis: Symptom Burden on Ocrelizumab: A Longitudinal Study (SymBOLS) by Kister, Ilya, Oh, Cheongeun, Douglas, Elizabeth A., Bacon, Tamar E., O'Shea, Isabella L., Parrotta, Erica H., Bouley, Andrew, Lathi, Ellen, Katz, Joshua

“…Background and ObjectivesSome patients with multiple sclerosis (MS) receiving ocrelizumab (OCR) report worsening symptoms toward the end of the 6-month…”
Get full text

Effects of Disease Modifying Therapy (DMT) Exposure on infant birth weight and birth length: Interim Data from Prospective PREG-MS Cohort. (4481) by Pol-Patil, Jeta, Maneiri, Maria Claudia, Mahlanza, Tatenda Dawn, Klawiter, Eric, Solomon, Andrew, Lathi, Ellen, Ionete, Carolina, Morales, Idanis Berrios, Severson, Christopher, Stankiewicz, James, Cabot, Ann, Katz, Joshua, Sadovnick, Adele Dessa, Chaves, Claudia, Bhattacharyya, Shamik, Kimbrough, Dorlan, Baber, Ursela, Beretich, Biljana, Rizvi, Syed, Napoli, Salvatore, Chitnis, Tanuja, Singhal, Tarun, Kaplan, Tamara, Houtchens, Maria

“…Abstract only…”
Get full text

Assessing no evidence of disease activity status in patients with relapsing–remitting multiple sclerosis receiving fingolimod: results from a longitudinal, multicenter, real-world study (P4.388) by Weinstock-Guttman, Bianca, Medin, Jennie, Khan, Nasreen, Korn, Jonathan, Price, Jenny, Silva, Diego, Lathi, Ellen, Silversteen, Jason, Edwards, Keith, Zivadinov, Robert

“…Abstract only…”
Get full text

Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk by Patsopoulos, Nikolaos A., Beecham, Ashley H., Goris, An, Dubois, Bénédicte, D’hooghe, Marie B., Van Damme, Philip, Søndergaard, Helle Bach, Sellebjerg, Finn, Ullum, Henrik, Thørner, Lise W., Werge, Thomas, Damotte, Vincent, Fontaine, Bertrand, Lathrop, Mark, Gourraud, Pierre-Antoine, Pongratz, Viola, Gasperi, Christiane, Bayas, Antonios, Heesen, Christoph, Linker, Ralf, Paul, Friedemann, Stangel, Martin, Tackenberg, Björn, Bergh, Florian Then, Wildemann, Brigitte, Tumani, Hayrettin, Gold, Ralf, Grummel, Verena, Knier, Benjamin, Lill, Christina M., Dardiotis, Efthimios, Agliardi, Cristina, Barizzone, Nadia, Mascia, Elisabetta, Bernardinelli, Luisa, Cusi, Daniele, Ferrè, Laura, Comi, Cristoforo, Galimberti, Daniela, Leone, Maurizio A., Mescheriakova, Julia, Hintzen, Rogier, van Duijn, Cornelia, Teunissen, Charlotte E., Bos, Steffan D., Myhr, Kjell-Morten, Celius, Elisabeth G., Lie, Benedicte A., Comabella, Manuel, Montalban, Xavier, Alfredsson, Lars, Stridh, Pernilla, Hillert, Jan, Piehl, Fredrik, Jelčić, Ilijas, Martin, Roland, Sospedra, Mireia, Hawkins, Clive, Hysi, Pirro, Karpe, Fredrik, Khadake, Jyoti, Lachance, Genevieve, Neville, Matthew, Santaniello, Adam, Caillier, Stacy J., Calabresi, Peter A., Cross, Anne, Davis, Mary F., de Bakker, Paul I.W., Delgado, Silvia, Dembele, Marieme, Edwards, Keith, Fitzgerald, Kathryn C., Hakonarson, Hakon, Konidari, Ioanna, Lathi, Ellen, Manrique, Clara P., Pericak-Vance, Margaret A., Piccio, Laura, Schaefer, Cathy, McCabe, Cristin, Hadjigeorgiou, Georgios, Taylor, Bruce, Tajouri, Lotti, Charlesworth, Jac, Booth, David R., Harbo, Hanne F., Ivinson, Adrian J., Hauser, Stephen L., Compston, Alastair, Stewart, Graeme, Zipp, Frauke, Barcellos, Lisa F., Baranzini, Sergio E., Martinelli-Boneschi, Filippo, Ziegler, Andreas, McCauley, Jacob L., Sawcer, Stephen J., De Jager, Philip L., Kockum, Ingrid

Get full text

A review of disease-modifying therapies for MS: maximizing adherence and minimizing adverse events by Brandes, David W., Callender, Teri, Lathi, Ellen, O'Leary, Shirley

“…ABSTRACT Background: In a chronic disabling disorder such as multiple sclerosis (MS), adherence to treatment is of critical importance in maximizing benefits…”
Get full text

Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk by Patsopoulos, Nikolaos A., Beecham, Ashley H., Goris, An, Dubois, Bénédicte, D’hooghe, Marie B., Van Damme, Philip, Søndergaard, Helle Bach, Sellebjerg, Finn, Ullum, Henrik, Thørner, Lise W., Werge, Thomas, Damotte, Vincent, Fontaine, Bertrand, Lathrop, Mark, Gourraud, Pierre-Antoine, Pongratz, Viola, Gasperi, Christiane, Bayas, Antonios, Heesen, Christoph, Linker, Ralf, Paul, Friedemann, Stangel, Martin, Tackenberg, Björn, Bergh, Florian Then, Wildemann, Brigitte, Tumani, Hayrettin, Gold, Ralf, Grummel, Verena, Knier, Benjamin, Lill, Christina M., Dardiotis, Efthimios, Agliardi, Cristina, Barizzone, Nadia, Mascia, Elisabetta, Bernardinelli, Luisa, Cusi, Daniele, Ferrè, Laura, Comi, Cristoforo, Galimberti, Daniela, Leone, Maurizio A., Mescheriakova, Julia, Hintzen, Rogier, van Duijn, Cornelia, Teunissen, Charlotte E., Bos, Steffan D., Myhr, Kjell-Morten, Celius, Elisabeth G., Lie, Benedicte A., Comabella, Manuel, Montalban, Xavier, Alfredsson, Lars, Stridh, Pernilla, Hillert, Jan, Piehl, Fredrik, Jelčić, Ilijas, Martin, Roland, Sospedra, Mireia, Hawkins, Clive, Hysi, Pirro, Karpe, Fredrik, Khadake, Jyoti, Lachance, Genevieve, Neville, Matthew, Santaniello, Adam, Caillier, Stacy J., Calabresi, Peter A., Cross, Anne, Davis, Mary F., de Bakker, Paul I.W., Delgado, Silvia, Dembele, Marieme, Edwards, Keith, Fitzgerald, Kathryn C., Hakonarson, Hakon, Konidari, Ioanna, Lathi, Ellen, Manrique, Clara P., Pericak-Vance, Margaret A., Piccio, Laura, Schaefer, Cathy, McCabe, Cristin, Hadjigeorgiou, Georgios, Taylor, Bruce, Tajouri, Lotti, Charlesworth, Jac, Booth, David R., Harbo, Hanne F., Ivinson, Adrian J., Hauser, Stephen L., Compston, Alastair, Stewart, Graeme, Zipp, Frauke, Barcellos, Lisa F., Baranzini, Sergio E., Martinelli-Boneschi, Filippo, Ziegler, Andreas, McCauley, Jacob L., Sawcer, Stephen J., De Jager, Philip L., Kockum, Ingrid

Get full text

Learning from Our Errors by Brown, Jeremy, Worthington, Michael G, Lathi, Ellen S

“…Stage A 50-year-old black man was brought to the emergency room. He had been unable to move his legs for four days and complained of impaired speech. Response…”
Get full text

Alternate dosing of fingolimod for Multiple Sclerosis (S31.007) by Kister, Ilya, Kantor, Daniel, Khoury, Samia, Rice, Marcus, Lathi, Ellen, Rodriguez, Ana Belen Caminero, Pawate, Siddharama, Bradshaw, Michael, Edwards, Keith, Cross, Anne, Parks, Becky, Lynch, Jennifer, Archer, Robert, Meador, William, Berkovich, Regina, Yamout, Bassem, Zeineddine, Maya, VanderKodde, Danita, Von Geldern, Gloria, Ge, Lily, Russell, Shira, Bacon, Tamar, Longbrake, Erin

“…Abstract only…”
Get full text

A New England COVID-19 Registry of Patients With CNS Demyelinating Disease: A Pilot Analysis by Money, Kelli M., Mahatoo, Ashmanie, Samaan, Soleil, Anand, Pria, Baber, Ursela, Bailey, Mary, Bakshi, Rohit, Bouley, Andrew, Bower, Aaron, Cahill, Jonathan, Houtchens, Maria, Katz, Joshua, Lathi, Ellen, Levit, Elle, Longbrake, Erin E., McAdams, Matthew, Napoli, Salvatore, Raibagkar, Pooja, Wade, Peter, Sloane, Jacob A.

“…We sought to define the risk of severe coronavirus disease 2019 (COVID-19) infection requiring hospitalization in patients with CNS demyelinating diseases such…”
Get full text